Jerome Detreille’s Post

There you are, thank goodness you're here! We have so much to catch up on: - #integrated #engineering project execution - Process #simulation for enhanced production - #process mapping, #characterization and #optimization - #fasttrack skid and process system delivery #bioprocessing #biopharmaceuticals #biomanufacturing #ISPEProductShow

Apropos the topic of #pharma40 and #digitalization in the #biopharmaceutical space, this will be a talk not to be missed. If you aren't attending the #ispeFoF Facilities of the Future conference in #sanfrancisco next week, let me know and I can get you the transcript. #ZETA #ISPE #biomanufacturing

Heading home after a very good SAE Media conference covering Pre-filled Syringes and Injectable Drug Devices. Key themes carried over from 2023 included connectivity, sustainability, high viscosity formulations and regulatory change, but with many updates and fresh perspectives and lots more besides. The event also stood out for some great Q&A discussions - as well as some excellent speakers, panels and session chairs I think the smaller size of the conference contributed significantly to this. Bigger is not necessarily better! Two other recurring themes were the benefits of effective collaboration and the need to kick-off new device developments early. If you would like to find out more about how Team can help with each of these, please get in touch! #devicedevelopment #drugdelivery  #teamconsulting

The R&D 15: Top pharma players shell out record $153B for research, and M&A is a prime focus for all At a time when biotech is still counting its losses as a thaw gradually sets in after the long market winter, pharma has been on a tear. M&A took off in Q4 as the industry’s biggest R&D spenders either rolled the dice on the back of their blockbuster bonanzas, were forced to address gaping holes in the pipeline in the face of looming patent expirations, or simply had no choice in the face of repeated setbacks. https://lnkd.in/gFgaFbv7

Core Elements of Global Drug and Medical Devices Manufacturing & Commercialisation Challenges - 2024-2044 Best Wishes - 2024 #intellitronresearch #drugdevelopment #medicaldevicemanufacturing #regulatorycompliance #technologicaladvancements #researchanddevelopment #qualitycontrol #qualityassurance #marketaccess #regulatoryaffairs

Had a great conversation with Doug Drysdale about the future of Cybin Inc and what we can expect from the company in both finance and research spheres. It's always a pleasure to have such a passionate and well-spoken CEO on The Dales Report, and chatting with Doug almost makes my job too easy. In this interview, Doug and I dive into the company's Small Pharma acquisition, the future of FDA approval, psychedelic treatments for homelessness as outlined by NYC's mayor, and what investors can look forward to from the company and in the biotech industry as a whole. Watch and subscribe over on our YouTube channel, linked below. #psychedelicmedicine #psychedelictherapy #psychedelicresearch #investoreducation #investors

🤝💼 𝐅𝐮𝐭𝐮𝐫𝐚 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐒𝐞𝐚𝐥𝐬 𝐚𝐧 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐃𝐞𝐚𝐥 𝐰𝐢𝐭𝐡 𝐇𝐚𝐥𝐞𝐨𝐧 𝐓𝐨 𝐋𝐚𝐮𝐧𝐜𝐡 𝐆𝐞𝐥-𝐁𝐚𝐬𝐞𝐝 𝐌𝐄𝐃3000 - 𝐀 𝐆𝐚𝐦𝐞 𝐂𝐡𝐚𝐧𝐠𝐞𝐫 𝐢𝐧 𝐄𝐃 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭, 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐒!🚀 The first over-the-counter erectile dysfunction gel, MED3000, also known as #Eroxon, is now available to patients in the US following recent FDA approval. Haleon, a spin-off from GSK, will handle the US rollout of Eroxon, overseeing regulatory, development, marketing, and commercialisation. In this synergy, Futura Medical will gain an upfront windfall of $4m💰, royalties on Eroxon sales, and stand to earn up to $45m in commercial and sales milestone achievements. 📊💹𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐢𝐧𝐠 𝐟𝐚𝐜𝐭: Following this news, Futura shares kick-started Monday, 17th July, with a vigorous 12% leap from Friday's close 𝐇𝐨𝐰 𝐝𝐨 𝐲𝐨𝐮 𝐬𝐞𝐞 𝐭𝐡𝐢𝐬 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐢𝐧𝐟𝐥𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐦𝐞𝐧'𝐬 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐨𝐯𝐞𝐫-𝐭𝐡𝐞-𝐜𝐨𝐮𝐧𝐭𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬? 🤔💡 𝐋𝐞𝐭'𝐬 𝐡𝐞𝐚𝐫 𝐲𝐨𝐮𝐫 𝐭𝐡𝐨𝐮𝐠𝐡𝐭𝐬! Source: Nicholas Hall Group of Companies #CHCNewsFlash #CHCTA #NicholasHall

Earlier this month, the FDA's CBER Office of Therapeutic Products hosted a webinar to discuss the recently finalized guidance for CAR T cell product development. One key takeaway from the virtual session was that Chain of Identity (COI) management is essential for IND applications: “Maintenance of the Chain of Identity should be described in the IND and validated for licensure.” The good news is - our supply chain orchestration system, OCELLOS, provides a seamless COI audit trail, which aligns with FDA expectations. Book a demo today to see OCELLOS could help scale-out your therapies: https://loom.ly/XvieiLU #CGT #FDA #COI #OCELLOS #CellularOrchestration #DigitalSupplyChain

Discover how Phoenix Pharma at Auhof Center, Austria, reduced the time and effort that staff spends daily by implementing SOLUM's Newton Electronic Shelf Labels in their retail operations. The Phoenix Pharma team is currently gaining so much from utilizing the labels' features for two years now. LEARN MORE: https://lnkd.in/gtew276Z #PhoenixPharma #SOLUM #SOLUMESL #ESL #Newton #NewtonESL #electronicshelflabels #electronicpricetags #digitalpricetags #digitallabels #digitalsignages #pharmacy #drugstore #apothecary #CaseStudy #CustomerFeedback #ClientTestimonial

For many of you who have or are looking into EM systems for your cleanrooms this is an excellent webinar.